Avanos Medical (NYSE:AVNS) Updates FY 2025 Earnings Guidance

Avanos Medical (NYSE:AVNS - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.750-0.950 for the period, compared to the consensus earnings per share estimate of 1.120. The company issued revenue guidance of $665.0 million-$685.0 million, compared to the consensus revenue estimate of $673.5 million.

Avanos Medical Trading Down 1.2 %

Shares of Avanos Medical stock opened at $12.14 on Tuesday. The stock's 50 day simple moving average is $13.62 and its 200-day simple moving average is $16.26. The stock has a market cap of $558.66 million, a P/E ratio of 35.72 and a beta of 1.13. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. Avanos Medical has a 1-year low of $11.84 and a 1-year high of $25.36.

Avanos Medical (NYSE:AVNS - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.07. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. Analysts predict that Avanos Medical will post 1.32 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of Avanos Medical from a "hold" rating to a "buy" rating in a research note on Wednesday, March 19th.

Insiders Place Their Bets

In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of the firm's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $15.25, for a total transaction of $106,750.00. Following the sale, the senior vice president now owns 82,047 shares of the company's stock, valued at approximately $1,251,216.75. This trade represents a 7.86 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.64% of the stock is currently owned by company insiders.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.